AVEO Pharmaceuticals Inc is a biopharmaceutical company. It is involved in discovering, developing and commercializing novel cancer therapeutics.
| Website: | www.aveooncology.com |
| Main Phone: | +1 617 588-1960 |
| Address: | One Broadway |
| Address 2: | 14th Floor |
| State: | MA |
| City / Town: | Cambridge |
| Country: | USA |
| Postal Code: | 02142 |
| Exchange: | NGS |
| Employees: | 19 |
| NAICS: | Pharmaceutical P |
| Last Price 2.59 | Change $ -0.06 | Change % -2.26 | Tick N/A |
| Bid 2.57 | Bid Size 400.00 | Ask 2.64 | Ask Size 2,000.00 |
| Open 2.65 | High 2.67 | Low 2.56 | Prev Close 2.65 |
| Last Trade | Volume 1.3 mi | 52 Wk Hi 4.24 | 52 Wk Low 0.57 |
| Market Cap 307.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 118,867,471.00 | EPS (TTM) -0.58 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 10 |
| Number of Buys | 0 | 10 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 1088078 |
| Last 10 Buys | Shares |
|---|---|
| Henri A. Termeer | 1,000 |
| Robert C. Young | 1,000 |
| Robert C. Young | 1,000 |
| Robert C. Young | 1,000 |
| Henri A. Termeer | 1,000 |
| Raju S. Kucherlapati | 1,000 |
| Raju S. Kucherlapati | 1,000 |
| Henri A. Termeer | 1,000 |
| Robert C. Young | 1,000 |
| Robert C. Young | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Matthew Dallas | 1,000 |
| Michael P. Bailey | 1,000 |
| Matthew Dallas | 1,000 |
| Joseph Vittiglio | 1,000 |
| Jeno Gyuris | 1,000 |
| Joseph Vittiglio | 1,000 |
| Jeno Gyuris | 1,000 |
| William Slichenmyer | 1,000 |
| Michael P. Bailey | 1,000 |
| David Johnston | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 1.7 | 1.7 | 1.7 | 1.75 |
| Mean Target Price Estimate | 2.35 | 2.35 | 2.35 | 2.38 |
| Standard Deviation | 0.92 | 0.92 | 0.92 | 0.88 |
| Date of Most Recent Estimate | 08/05/16 | 08/05/16 | 08/05/16 | 08/12/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2016-08-04 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 97 | 2016-08-04 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 18 | 2016-07-01 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-06-30 |
| CT ORDER | 1 | 2016-06-20 | |
| CT ORDER | 1 | 2016-06-20 | |
| CT ORDER | 1 | 2016-06-16 | |
| S-3 | Simplified registration form | 27 | 2016-06-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 41 | 2016-06-15 |
| SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% | 27 | 2016-05-31 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
